Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Patent Reform Consensus Supports New Reexamination System, Sen. Hatch

Executive Summary

Initial patent reform consensus supports a new system for patent reexamination, Senate Judiciary Intellectual Property Subcommittee Chairman Orrin Hatch (R-Utah) said April 25

You may also be interested in...



Patent Reform Bill Drops Changes To Injunctive Relief In Revised Draft

The latest draft of Rep. Lamar Smith's (R-Texas) "Patent Reform Act" drops proposed changes to injunctive relief standards that had been opposed by the pharmaceutical industry

Patent Reform Bill Drops Changes To Injunctive Relief In Revised Draft

The latest draft of Rep. Lamar Smith's (R-Texas) "Patent Reform Act" drops proposed changes to injunctive relief standards that had been opposed by the pharmaceutical industry

Patent Reform Bill Sets Excessively High Bar For Injunctions, Attorney Says

Tightened injunctive relief standards included in a House patent reform bill could be detrimental to the pharmaceutical industry, Sidley Austin Brown & Wood Partner Jeffrey Kushan stated

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045753

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel